Home / Inspections / 1291316

FDA Inspection 1291316 — Takeda Austria GmbH

Takeda Austria GmbH — FEI 3001157285

The FDA completed an inspection of Takeda Austria GmbH on September 11, 2025 in Linz. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 11, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Linz (Austria)

Facility

Other inspections at this facility

  • 1279948 (VAI Fri Feb 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1078546 (VAI Fri Nov 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1002607 (VAI Mon Jan 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926808 (VAI Thu May 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 646574 (VAI Thu Feb 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources